HHS, Regeneron Collaborate to Develop 2019-nCoV Treatment

05. February 2020 EHR, EMR, Health, HIPAA 0
To develop therapeutics to treat the 2019 novel coronavirus, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) will expand an existing collaboration with Regeneron Pharmaceuticals Inc. of Tarrytown, New York. “Emerging infectious diseases can present serious threats to our nation’s health security,” said Rick Bright, ...